Who should get a liver graft?

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 67, Issue 3, Pages (September 2017)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
MELD: the holy grail of organ allocation?
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Liver transplantation using Donation after Cardiac Death donors
Volume 68, Issue 5, Pages (May 2018)
Primary prevention of variceal haemorrhage: A pharmacological approach
Volume 61, Issue 6, Pages (December 2014)
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis
Marcus-Alexander Wörns, Peter Robert Galle  Journal of Hepatology 
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Volume 66, Issue 1, Pages 1-4 (January 2017)
Living donor liver transplantation: is the hype over?
What lessons have we learned in pediatric liver transplantation?
Reply to: “DCD consensus and futility in liver transplantation”
Volume 69, Issue 2, Pages (August 2018)
The place of downstaging for hepatocellular carcinoma
Volume 58, Issue 3, Pages (March 2013)
Mauro Bernardi, Stefano Gitto, Maurizio Biselli  Journal of Hepatology 
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Volume 68, Issue 1, Pages (January 2018)
Familial amyloid polyneuropathy and liver transplantation
Hepatitis C core protein – The “core” of immune deception?
Volume 124, Issue 1, Pages (January 2003)
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Why men are at higher risk for hepatocellular carcinoma?
Volume 62, Issue 3, Pages (March 2015)
Genomic risk of hepatitis C-related hepatocellular carcinoma
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
The heart in liver transplantation
The changing role of beta-blocker therapy in patients with cirrhosis
Volume 65, Issue 2, Pages (August 2016)
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Immigration and viral hepatitis
Volume 57, Issue 3, Pages (September 2012)
Evolution of liver transplantation for hepatocellular carcinoma
HCV targeting of patients with cirrhosis
Volume 63, Issue 1, Pages (July 2015)
The use of hemospray in portal hypertensive bleeding; a case series
Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence  Christian Toso, Gilles Mentha, Pietro.
Volume 66, Issue 4, Pages (April 2017)
New trials and results in systemic treatment of HCC
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Donor-recipient matching: Myths and realities
Chimeric mouse model of hepatitis B virus infection
Volume 50, Issue 1, Pages 4-6 (January 2009)
Genetics of hepatocellular carcinoma: The next generation
MELD: the holy grail of organ allocation?
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Volume 70, Issue 5, Pages (May 2019)
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Who should get a liver graft? Richard B. Freeman, Neville Jamieson, Douglas E. Schaubel, Robert J. Porte, Federico G. Villamil  Journal of Hepatology  Volume 50, Issue 4, Pages 664-673 (April 2009) DOI: 10.1016/j.jhep.2009.01.013 Copyright © 2009 Terms and Conditions

Fig. 1 Overall dropout rates for HCC and non-HCC candidates, listed 4/14/04-12/31/07 on the UNOS/OPTN liver transplant waiting list using a competing risks statistical technique. All calculations are done from time of listing for non HCC patients and from time of first HCC application acceptance for HCC patients. (courtesy of Dr. Erick Edwards, used with permission.) Journal of Hepatology 2009 50, 664-673DOI: (10.1016/j.jhep.2009.01.013) Copyright © 2009 Terms and Conditions